LionBird II Overview

  • Fund Type
  • Venture

  • Fund Status
  • Closed

  • Size

  • Vintage
  • 2016

Vintage

  • Dry Powder

LionBird II General Information

Description

LionBird II is a 2016 vintage early-stage venture capital fund managed by LionBird. The fund is located in Tel Aviv, Israel, and the United States, and Israel. The fund invests in healthcare devices, and supplies sectors. The fund prefers to invest USD 0.5 million to USD 2 million per company.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Open Date
Close Date
Fund Family
LionBird
Native Currency
USD
Fund Manager's Location
  • 25 HaBarzel Street
  • Tel Aviv 69710
  • Israel
+972
Fund Domiciles
Cayman Islands

LionBird II Investments (24)

LionBird II has made a total of 24 investments. Its most recent deal was a with Maverick Medical AI for . The deal was made on 23-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Maverick Medical AI 23-Feb-2025 Other Healthcare Technology Systems Generating Revenue
C2i Genomics 24-May-2020 Decision/Risk Analysis Generating Revenue
Brainvivo 30-Oct-2019 Biotechnology Generating Revenue
Protenus 20-Aug-2019 Enterprise Systems (Healthcare) Generating Revenue
Droom 20-Jun-2019 Automotive Generating Revenue
Bizzabo 17-Apr-2019 Business/Productivity Software Generating Revenue
Remesh 12-Apr-2019 Business/Productivity Software Generating Revenue
Theranica 18-Mar-2019 Therapeutic Devices Generating Revenue
TytoCare 16-Jan-2019 Later Stage VC (Series C) Monitoring Equipment Generating Revenue
FundGuard 20-Dec-2018 Seed Round Other Capital Markets/Institutions Generating Revenue
You’re viewing 10 of 24 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LionBird II Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

LionBird II Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

LionBird II Returns History

Period Contribution (by all LPs) Dry Powder Distribution (to all LPs) NAV Total Fund Distr+NAV IRR DPI RVPI TVPI Dry Powder %

This information is available in the PitchBook Platform. To explore LionBird II‘s full profile, request access.

Request a free trial

LionBird II FAQs

  • What is LionBird II?

    LionBird II is a 2016 vintage early-stage venture capital fund managed by LionBird.

  • Who manages LionBird II?

    LionBird II is managed by LionBird.

  • Where is LionBird II domiciled?

    LionBird II is domiciled in Cayman Islands.

  • What is LionBird II's size?

    LionBird II has a size of .

  • What type of fund is LionBird II?

    The fund type of LionBird II is Venture.

  • What is the status of LionBird II?

    LionBird II is closed.

  • What has LionBird II invested in?

    LionBird II has made numerous investments in companies like Maverick Medical AI, C2i Genomics, and Brainvivo within the Healthcare Technology Systems, Decision/Risk Analysis, and Biotechnology industries.

  • What has LionBird II invested in recently?

    LionBird II's latest investment was on 23-Feb-2025 in Maverick Medical AI, a company within the Healthcare Technology Systems industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »